BioNTech, Pfizer studying new COVID variant

News Department
Post's author

BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.

“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.

The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.

Latest news

Armenian PM: Eduard Hakobyan to be appointed head of State Revenue Committee 26 November, 2024 / 12:04
Tax Service: Environmental sustainability is covered by state incentive instruments in Azerbaijan 26 November, 2024 / 11:48
Azerbaijan, China's Xi'an Port discuss expanding collaboration 26 November, 2024 / 11:46
SOCAR discusses geothermal energy and carbon capture with US company 26 November, 2024 / 11:35
Putin emphasizes need to prevent destabilization in CIS space 26 November, 2024 / 11:33
‘Made in Turan’ brand to bring Turkic states' products to market 26 November, 2024 / 11:29
Moratinos: Despite various opinions, Azerbaijan's hosting of COP29 was at high level 26 November, 2024 / 11:22
Armenia to cut most of Foreign Ministry's service vehicles 26 November, 2024 / 11:20
Russian lawmakers introduce bill to temporarily lift Taliban ban 26 November, 2024 / 11:14
At least 12 killed in opposition protests in Islamabad 26 November, 2024 / 10:56
bp announces new appointments in AGT leadership 26 November, 2024 / 10:42
UN to promote Azerbaijan's ASAN Service model across four continents 26 November, 2024 / 10:34
Turkish interior minister: Over 50 suspects with ISIS links detained 26 November, 2024 / 10:33
30th anniversary of Azerbaijan's joining to NATO's PfP program celebrated in Baku 26 November, 2024 / 10:07
Brent crude rises to $73.28 per barrel 26 November, 2024 / 10:02